HIIFS
INDP icon

Harel Insurance Investments & Financial Services’s Indaptus Therapeutics INDP Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio INDP Stock Details INDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4
Closed – – 717
2022
Q4 		$0 Hold
4
– – ﹤0.01% 710
2022
Q3 		$0 Sell
4
-99
-96% -$7.71K ﹤0.01% 721
2022
Q2 		$7K Buy
+103
New +$8.04K ﹤0.01% 680
2022
Q1 		– Sell
-106
Closed -$16K – 761
2021
Q4 		$16K Hold
106
– – ﹤0.01% 682
2021
Q3 		$25K Buy
+106
New +$30.6K ﹤0.01% 606
2021
Q2 		– Hold
0
– – – 818
2020
Q4 		– Sell
-175
Closed -$99K – 751
2020
Q3 		$99K Buy
175
+11
+7% +$8.09K ﹤0.01% 397
2020
Q2 		$104K Buy
+164
New +$101K ﹤0.01% 326
2020
Q1 		– Sell
-164
Closed -$124K – 485
2019
Q4 		$184K Sell
164
-73
-31% -$101K 0.01% 212
2019
Q3 		$387K Sell
237
-42
-15% -$125K 0.02% 134
2019
Q2 		$2.71M Buy
279
+260
+1,368% +$3.28M 0.14% 62
2019
Q1 		$318K Sell
19
-266
-93% -$4.66M 0.02% 97
2018
Q4 		$4.81M Sell
285
-9
-3% -$123K 0.3% 55
2018
Q3 		$3.72M Buy
294
+281
+2,162% +$2.67M 0.18% 64
2018
Q2 		$132K Buy
+13
New +$144K 0.01% 228

Other funds holding INDP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $2.21B AUM 39.6% 1-Year Est. Return
SAM
Strategy Asset Managers Pasadena, California $670M AUM 34.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PVI
Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return
VCM
Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Harel Insurance Investments & Financial Services's INDP Position: Q1 2023 in Review

Harel Insurance Investments & Financial Services sold out of Indaptus Therapeutics (INDP) in Q1 2023, closing a stake of 4 shares.

Harel Insurance Investments & Financial Services first reported a position in INDP in Q2 2018 and held it in 14 quarters. The position peaked at $4.81M in Q4 2018. 14 funds tracked by Wall St. Rank hold INDP as of Q1 2023.

  • Harel Insurance Investments & Financial Services reported no remaining Indaptus Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 4 Indaptus Therapeutics shares in Q1 2023.
  • Harel Insurance Investments & Financial Services first reported a position in Indaptus Therapeutics in Q2 2018 and held it in 14 quarters.
  • Harel Insurance Investments & Financial Services's Indaptus Therapeutics position peaked at $4.81M in Q4 2018.
  • 14 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q1 2023.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q1 2023, filed 2 May 2023.